Retroperitoneal Lymphadenectomy in High-Risk Non-Metastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial.
about
The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT2-3 non-metastatic renal cell carcinoma treated with radical nephrectomy.The contemporary role of lymph node dissection in the management of renal cell carcinomaA Festschrift in Honor of Edward M. Messing, MD, FACS
P2860
Retroperitoneal Lymphadenectomy in High-Risk Non-Metastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Retroperitoneal Lymphadenectom ...... OG-ACRIN 2805) Adjuvant Trial.
@en
type
label
Retroperitoneal Lymphadenectom ...... OG-ACRIN 2805) Adjuvant Trial.
@en
prefLabel
Retroperitoneal Lymphadenectom ...... OG-ACRIN 2805) Adjuvant Trial.
@en
P2093
P2860
P1476
Retroperitoneal Lymphadenectom ...... OG-ACRIN 2805) Adjuvant Trial.
@en
P2093
Benjamin T Ristau
Christopher G Wood
Christopher J Kane
Daniel Y C Heng
Edward M Messing
Judi Manola
Naomi B Haas
Robert G Uzzo
Robert S DiPaola
P2860
P356
10.1016/J.JURO.2017.07.042
P407
P577
2017-07-17T00:00:00Z